These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
669 related articles for article (PubMed ID: 31801915)
1. Generation of novel Il2rg-knockout mice with clustered regularly interspaced short palindromic repeats (CRISPR) and Cas9. Byambaa S; Uosaki H; Hara H; Nagao Y; Abe T; Shibata H; Nureki O; Ohmori T; Hanazono Y Exp Anim; 2020 Apr; 69(2):189-198. PubMed ID: 31801915 [TBL] [Abstract][Full Text] [Related]
2. Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1. Schiroli G; Ferrari S; Conway A; Jacob A; Capo V; Albano L; Plati T; Castiello MC; Sanvito F; Gennery AR; Bovolenta C; Palchaudhuri R; Scadden DT; Holmes MC; Villa A; Sitia G; Lombardo A; Genovese P; Naldini L Sci Transl Med; 2017 Oct; 9(411):. PubMed ID: 29021165 [TBL] [Abstract][Full Text] [Related]
3. Generation of knockout rabbits with X-linked severe combined immunodeficiency (X-SCID) using CRISPR/Cas9. Hashikawa Y; Hayashi R; Tajima M; Okubo T; Azuma S; Kuwamura M; Takai N; Osada Y; Kunihiro Y; Mashimo T; Nishida K Sci Rep; 2020 Jun; 10(1):9957. PubMed ID: 32561775 [TBL] [Abstract][Full Text] [Related]
4. CRISPR-Mediated Knockout of Cybb in NSG Mice Establishes a Model of Chronic Granulomatous Disease for Human Stem-Cell Gene Therapy Transplants. Sweeney CL; Choi U; Liu C; Koontz S; Ha SK; Malech HL Hum Gene Ther; 2017 Jul; 28(7):565-575. PubMed ID: 28264583 [TBL] [Abstract][Full Text] [Related]
5. Biological Characteristics of Severe Combined Immunodeficient Mice Produced by CRISPR/Cas9-Mediated Zhao Y; Liu P; Xin Z; Shi C; Bai Y; Sun X; Zhao Y; Wang X; Liu L; Zhao X; Chen Z; Zhang H Front Genet; 2019; 10():401. PubMed ID: 31134127 [TBL] [Abstract][Full Text] [Related]
7. Off- and on-target effects of genome editing in mouse embryos. Ayabe S; Nakashima K; Yoshiki A J Reprod Dev; 2019 Feb; 65(1):1-5. PubMed ID: 30518723 [TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9 System and its Research Progress in Gene Therapy. Liu W; Yang C; Liu Y; Jiang G Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477 [TBL] [Abstract][Full Text] [Related]
9. Optimisation of the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 : single-guide RNA (sgRNA) delivery system in a goat model. Huang Y; Ding Y; Liu Y; Zhou S; Ding Q; Yan H; Ma B; Zhao X; Wang X; Chen Y Reprod Fertil Dev; 2019 Aug; 31(9):1533-1537. PubMed ID: 31079595 [TBL] [Abstract][Full Text] [Related]
10. Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing. Hou Y; Ureña-Bailén G; Mohammadian Gol T; Gratz PG; Gratz HP; Roig-Merino A; Antony JS; Lamsfus-Calle A; Daniel-Moreno A; Handgretinger R; Mezger M Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553615 [TBL] [Abstract][Full Text] [Related]
11. Efficient genome editing of Brassica campestris based on the CRISPR/Cas9 system. Xiong X; Liu W; Jiang J; Xu L; Huang L; Cao J Mol Genet Genomics; 2019 Oct; 294(5):1251-1261. PubMed ID: 31129735 [TBL] [Abstract][Full Text] [Related]
12. Biallelic modification of IL2RG leads to severe combined immunodeficiency in pigs. Kang JT; Cho B; Ryu J; Ray C; Lee EJ; Yun YJ; Ahn S; Lee J; Ji DY; Jue N; Clark-Deener S; Lee K; Park KW Reprod Biol Endocrinol; 2016 Nov; 14(1):74. PubMed ID: 27809915 [TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg Wei X; Lai Y; Li B; Qin L; Xu Y; Lin S; Wang S; Wu Q; Liang Q; Huang G; Deng Q; Liu P; Wu D; Lai L; Yao Y; Li P Sci Rep; 2017 Aug; 7(1):7720. PubMed ID: 28798321 [TBL] [Abstract][Full Text] [Related]
14. Bacterial and Song J; Wang G; Hoenerhoff MJ; Ruan J; Yang D; Zhang J; Yang J; Lester PA; Sigler R; Bradley M; Eckley S; Cornelius K; Chen K; Kolls JK; Peng L; Ma L; Chen YE; Sun F; Xu J Front Immunol; 2018; 9():429. PubMed ID: 29593714 [TBL] [Abstract][Full Text] [Related]
15. A single blastocyst assay optimized for detecting CRISPR/Cas9 system-induced indel mutations in mice. Sakurai T; Watanabe S; Kamiyoshi A; Sato M; Shindo T BMC Biotechnol; 2014 Jul; 14():69. PubMed ID: 25042988 [TBL] [Abstract][Full Text] [Related]
16. A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9. Sui T; Lau YS; Liu D; Liu T; Xu L; Gao Y; Lai L; Li Z; Han R Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29871865 [TBL] [Abstract][Full Text] [Related]
17. Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 with improved proof-reading enhances homology-directed repair. Kato-Inui T; Takahashi G; Hsu S; Miyaoka Y Nucleic Acids Res; 2018 May; 46(9):4677-4688. PubMed ID: 29672770 [TBL] [Abstract][Full Text] [Related]
18. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research]. Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746 [TBL] [Abstract][Full Text] [Related]
19. Analysis of microsatellite instability in CRISPR/Cas9 editing mice. Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774 [TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro disease modeling with CRISPR/Cas9. Kato T; Takada S Brief Funct Genomics; 2017 Jan; 16(1):13-24. PubMed ID: 27497066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]